483
ImClone Systems, LLCImClone Systems, LLC – FDA 483, Mar 9, 2018
Record Details
An FDA inspection of ImClone Systems, LLC. d.b.a. Eli Lilly and Company in Branchburg, NJ, identified deficiencies in aseptic processing areas. The firm failed to conduct proper smoke studies for ISO 5 Bio Safety Cabinets and did not perform adequate media fills to simulate aseptic production operations, indicating issues with environmental monitoring and contamination prevention procedures.
View Company Profile
ID · 15bc1098-5ad2-4372-9bdf-209468afb7a5
Other documents for ImClone Systems, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.